Paxman AB (publ) (STO:PAX)

Market Cap	1.06B -34.7%
Revenue (ttm)	323.56M +22.9%
Net Income	-16.72M
EPS	-0.76
Shares Out	23.27M
PE Ratio	n/a
Forward PE	25.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,548
Average Volume	19,402
Open	46.50
Previous Close	45.55
Day's Range	45.00 - 47.55
52-Week Range	41.00 - 85.80
Beta	0.46
RSI	47.84
Earnings Date	May 22, 2026

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 144
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX